Literature DB >> 29420113

Risk Factors for Development of Rhegmatogenous Retinal Detachment in Patients with Uveitis.

Paradee Kunavisarut1, Titipol Srisomboon1, Direk Patikulsila1, Janejit Choovuthayakorn1, Nawat Watanachai1, Voraporn Chaikitmongkol1, Kessara Pathanapitoon1, Aniki Rothova2.   

Abstract

Purpose: To describe risk factors for development of rhegmatogenous retinal detachment (RRD) in patients with uveitis.
Methods: We performed a retrospective review of 411 consecutive human immunodeficiency virus-negative patients with uveitis (571 affected eyes) and report on prevalence, risk factors and visual outcomes of patients with RRD.
Results: Prevalence of RRD was 7% of all patients with uveitis. Multivariate analysis revealed that posterior uveitis and panuveitis were associated with RRD (P = 0.001). Strong association between RRD development and infectious uveitis was also observed (P = 0.009). Acute retinal necrosis (ARN) was firmly associated with RRD development (P = 0.016). Although anatomical success was obtained, functional outcome was poor. Poor visual outcomes at 6-month and 1-year follow-up were associated with initial VA < counting fingers (P = 0.05, P = 0.044). Conclusions: Prevalence of RRD in uveitis was 7% and development of RRD was encountered in posterior and panuveitis. Infectious uveitis (specifically ARN) formed a high risk for RRD.

Entities:  

Keywords:  Prevalence; Thailand; rhegmatogenous retinal detachment; uveitis; visual outcome

Year:  2018        PMID: 29420113     DOI: 10.1080/09273948.2018.1424343

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  2 in total

1.  Advances in the Diagnosis and Management of Acute Retinal Necrosis.

Authors:  Casey L Anthony; J Clay Bavinger; Steven Yeh
Journal:  Ann Eye Sci       Date:  2020-09-15

2.  Retinal Detachment After Endophthalmitis: Risk Factors and Outcomes.

Authors:  Tiantian Wang; Omar Moinuddin; Rebhi Abuzaitoun; Min Hwang; Cagri Besirli; Thomas J Wubben; David N Zacks
Journal:  Clin Ophthalmol       Date:  2021-04-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.